Compare MEDP & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | WMS |
|---|---|---|
| Founded | 1992 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.4B |
| IPO Year | 2016 | 2014 |
| Metric | MEDP | WMS |
|---|---|---|
| Price | $471.64 | $145.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $498.25 | $177.89 |
| AVG Volume (30 Days) | 435.8K | ★ 683.8K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | ★ 20.98 | N/A |
| EPS | ★ 15.28 | 5.02 |
| Revenue | N/A | ★ $2,904,245,000.00 |
| Revenue This Year | $13.11 | $5.33 |
| Revenue Next Year | $7.51 | $12.88 |
| P/E Ratio | $30.76 | ★ $29.53 |
| Revenue Growth | N/A | ★ 1.04 |
| 52 Week Low | $250.05 | $93.92 |
| 52 Week High | $628.92 | $179.32 |
| Indicator | MEDP | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 28.46 |
| Support Level | $457.41 | $143.91 |
| Resistance Level | $501.30 | $147.10 |
| Average True Range (ATR) | 17.34 | 5.19 |
| MACD | 7.68 | -3.22 |
| Stochastic Oscillator | 87.87 | 12.98 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.